BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22441374)

  • 1. An unusual histologic variant of necrobiotic xanthogranuloma.
    Ziemer M; Norgauer J; Simon JC; Koehler MJ
    Am J Dermatopathol; 2012 Apr; 34(2):e22-6. PubMed ID: 22441374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of necrobiotic xanthogranuloma with intravenous immunoglobulin.
    Rubinstein A; Wolf DJ; Granstein RD
    J Cutan Med Surg; 2013; 17(5):347-50. PubMed ID: 24067856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation.
    Hashemi P; Rashidi A; Chapas AM; Balfour EM
    Cutis; 2012 Jan; 89(1):41-4. PubMed ID: 22439311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
    Nockowski P; Woźniak Z; Reich A; Maj J
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrobiotic xanthogranuloma associated with a benign monoclonal gammopathy.
    Burdick AE; Sanchez J; Elgart GW
    Cutis; 2003 Jul; 72(1):47-50. PubMed ID: 12889715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrobiotic xanthogranuloma.
    Fernández-Herrera J; Pedraz J
    Semin Cutan Med Surg; 2007 Jun; 26(2):108-13. PubMed ID: 17544963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and pathologic correlation.
    Wood AJ; Wagner MV; Abbott JJ; Gibson LE
    Arch Dermatol; 2009 Mar; 145(3):279-84. PubMed ID: 19289757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration.
    Ghiasi N; Alavi A; Coutts PM; Ghazarian D; Sibbald RG
    Int J Low Extrem Wounds; 2012 Dec; 11(4):293-5. PubMed ID: 23222162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.
    Rongioletti F; Cozzani E; Parodi A
    J Cutan Pathol; 2010 Oct; 37(10):1084-7. PubMed ID: 19638067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin.
    Liszewski W; Wisniewski JD; Safah H; Boh EE
    Dermatol Ther; 2014; 27(5):268-71. PubMed ID: 24910296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrobiotic xanthogranuloma.
    Rose A; Robinson M; Kamino H; Latkowski JA
    Dermatol Online J; 2012 Dec; 18(12):30. PubMed ID: 23286820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized necrobiotic xanthogranuloma successfully treated with lenalidomide.
    Silapunt S; Chon SY
    J Drugs Dermatol; 2010 Mar; 9(3):273-6. PubMed ID: 20232591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone.
    Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
    Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
    Seastrom S; Bookout A; Hogan DJ
    Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.
    Efebera Y; Blanchard E; Allam C; Han A; Lee S; Munshi N
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):298-302. PubMed ID: 21658660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of necrobiotic xanthogranuloma - a systematic review.
    Miguel D; Lukacs J; Illing T; Elsner P
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapy of necrobiotic xanthogranuloma: a systematic review.
    Steinhelfer L; Kühnel T; Jägle H; Mayer S; Karrer S; Haubner F; Schreml S
    Orphanet J Rare Dis; 2022 Mar; 17(1):132. PubMed ID: 35331271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of necrobiotic xanthogranuloma with total glucosides of paeony.
    Li S; Chen AJ; Fang S; Li H
    Dermatol Ther; 2014; 27(5):304-6. PubMed ID: 24774012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.
    Higgins LS; Go RS; Dingli D; Kumar SK; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lust JA; Kapoor P; Leung N; Lin Y; Kourelis TV; Gertz MA; Kyle RA; Gonsalves WI
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):447-52. PubMed ID: 27238425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrobiotic xanthogranuloma associated with monoclonal gammopathy of unknown significance.
    Melguizo Moya I; Navarro Puerto MA; Grilo Reina A
    Med Clin (Barc); 2017 Dec; 149(11):509-510. PubMed ID: 28736067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.